Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05726253 · ClinicalTrials.gov registry record · Early Phase 1

Supportive Treatment and Antibiotics for Mild Pediatric Pneumonia

A Early Phase 1 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Completed
Registry status
Early Phase 1
Development phase
2
Enrollment target

NCT05726253 is a Early Phase 1 study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05726253, a Early Phase 1 study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

COMPLETED
Registry status
Early Phase 1
Development phase
2 participants
Enrollment target

Study Summary

National guidelines make two recommendations for treatment of young children with mild pneumonia - one to avoid routine antibiotics and another to use narrow-spectrum antibiotics. No studies have compared the effectiveness of these two approaches. This pilot study will evaluate study processes and feasibility of a future clinical trial that proposes to test whether low-risk children managed as outpatients with mild community-acquired pneumonia (CAP) treated with supportive treatment without antibiotics will have a similar clinical response, with fewer adverse effects, compared with those treated with a supportive treatment plan that includes antibiotics.

Interventions

  • DRUG Supportive Care + Amoxicillin
  • DRUG Supportive Care + Placebo (no antibiotics)

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2023-01-09
Est. Completion 2023-12-31
Phase Early Phase 1

What the Registry Record Tells You About NCT05726253

The ClinicalTrials.gov registry entry for NCT05726253 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Supportive Care + Amoxicillin is the first listed.

NCT05726253 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05726253 about?

NCT05726253 is a clinical study titled "Supportive Treatment and Antibiotics for Mild Pediatric Pneumonia". National guidelines make two recommendations for treatment of young children with mild pneumonia - one to avoid routine antibiotics and another to use narrow-spectrum antibiotics. No studies have compared the effectiveness of these two approaches. This pilot study will evaluate study processes and f...

What is the current status of trial NCT05726253?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2023-01-09. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT05726253?

The interventions under investigation include: Supportive Care + Amoxicillin (DRUG), Supportive Care + Placebo (no antibiotics) (DRUG).

Who is sponsoring clinical trial NCT05726253?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.